Summer Street Upgrades Arena Pharma (ARNA) to Neutral; Some Clarity From This Week’s FDA Meeting
Tweet Send to a Friend
Summer Street upgraded Arena Pharma (NASDAQ: ARNA) from Sell to Neutral.
Summer St. analyst says, "We have the US lorcaserin ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Summer St. analyst says, "We have the US lorcaserin ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
